Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outlook Therapeutics (OTLK) Interest Coverage Ratio (2016 - 2020)

Outlook Therapeutics (OTLK) has disclosed Interest Coverage Ratio for 6 consecutive years, with 26.78 as the latest value for Q2 2020.

  • Quarterly Interest Coverage Ratio fell 413.23% to 26.78 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was 138.92 through Jun 2025, changed N/A year-over-year, with the annual reading at 22.71 for FY2024, 8.22% down from the prior year.
  • Interest Coverage Ratio for Q2 2020 was 26.78 at Outlook Therapeutics, down from 9.72 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 15.74 in Q3 2018, with the low at 73.56 in Q2 2016.
  • Average Interest Coverage Ratio over 5 years is 15.45, with a median of 7.36 recorded in 2018.
  • The sharpest move saw Interest Coverage Ratio soared 1260.86% in 2018, then tumbled 483.75% in 2019.
  • Over 5 years, Interest Coverage Ratio stood at 36.38 in 2016, then surged by 87.82% to 4.43 in 2017, then crashed by 106.61% to 9.15 in 2018, then plummeted by 49.63% to 13.69 in 2019, then plummeted by 95.55% to 26.78 in 2020.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 26.78, 9.72, and 13.69 for Q2 2020, Q1 2020, and Q4 2019 respectively.